Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 895

Details

Autor(en) / Beteiligte
Titel
An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis
Ist Teil von
  • PloS one, 2012-09, Vol.7 (9), p.e45478-e45478
Ort / Verlag
United States: Public Library of Science
Erscheinungsjahr
2012
Quelle
MEDLINE
Beschreibungen/Notizen
  • The S100A9 and S100A8 proteins are highly expressed by neutrophils and monocytes and are part of a group of damage-associated molecular pattern molecules that trigger inflammatory responses. Sera and synovial fluids of patients with rheumatoid arthritis (RA) contain high concentrations of S100A8/A9 that correlate with disease activity. In this study, we investigated the importance of S100A9 in RA by using neutralizing antibodies in a murine lipopolysaccharide-synchronized collagen-induced arthritis model. We also used an in vitro model of stimulation of human immune cells to decipher the role played by S100A9 in leukocyte migration and pro-inflammatory cytokine secretion. Treatment with anti-S100A9 antibodies improved the clinical score by 50%, diminished immune cell infiltration, reduced inflammatory cytokines, both in serum and in the joints, and preserved bone/collagen integrity. Stimulation of neutrophils with S100A9 protein led to the enhancement of neutrophil transendothelial migration. S100A9 protein also induced the secretion by monocytes of proinflammatory cytokines like TNFα, IL-1β and IL-6, and of chemokines like MIP-1α and MCP-1. The effects of anti-S100A9 treatment are likely direct consequences of inhibiting the S100A9-mediated promotion of neutrophil transmigration and secretion of pro-inflammatory cytokines from monocytes. Collectively, our results show that treatment with anti-S100A9 may inhibit amplification of the immune response and help preserve tissue integrity. Therefore, S100A9 is a promising potential therapeutic target for inflammatory diseases like rheumatoid arthritis for which alternative therapeutic strategies are needed.
Sprache
Englisch
Identifikatoren
ISSN: 1932-6203
eISSN: 1932-6203
DOI: 10.1371/journal.pone.0045478
Titel-ID: cdi_plos_journals_1344509539
Format
Schlagworte
Animals, Antibodies, Antibodies, Monoclonal - immunology, Antibodies, Monoclonal - pharmacology, Antibodies, Neutralizing - immunology, Antibodies, Neutralizing - pharmacology, Arthritis, Arthritis, Experimental - immunology, Arthritis, Experimental - metabolism, Autoantibodies - blood, Autoantibodies - immunology, Biology, Bone and Bones - pathology, Calgranulin B - immunology, Calgranulin B - metabolism, Cartilage - pathology, Cell Adhesion - drug effects, Cell Adhesion - immunology, Chemokines, Collagen, Computational fluid dynamics, Cytokines, Cytokines - immunology, Cytokines - metabolism, Damage patterns, Development and progression, Disease, Experiments, Female, Fibroblasts, Genetic aspects, Humans, Immune response, Immune system, Infiltration, Inflammation, Inflammation - immunology, Inflammation - metabolism, Inflammation Mediators - immunology, Inflammation Mediators - metabolism, Inflammatory diseases, Integrity, Interleukin 6, Joint diseases, Leukocyte L1 Antigen Complex - immunology, Leukocyte L1 Antigen Complex - metabolism, Leukocyte migration, Leukocytes, Leukocytes (neutrophilic), Lipopolysaccharides, Medicine, Mice, Monocyte chemoattractant protein 1, Monocytes, Monocytes - drug effects, Monocytes - immunology, Neutrophils, Neutrophils - drug effects, Neutrophils - immunology, Proteins, Rheumatoid arthritis, Rheumatology, S100A9 protein, Stimulation, Transendothelial and Transepithelial Migration - drug effects, Transendothelial and Transepithelial Migration - immunology, Tumor Necrosis Factor-alpha - pharmacology, Tumor necrosis factor-TNF, Tumor necrosis factor-α

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX